Effect of height on ED50 and ED95 of intrathecal ropivacaine in pregnant patients undergoing cesarean delivery

Trial Profile

Effect of height on ED50 and ED95 of intrathecal ropivacaine in pregnant patients undergoing cesarean delivery

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Apr 2016

At a glance

  • Drugs Ropivacaine (Primary)
  • Indications Intraoperative pain
  • Focus Pharmacokinetics
  • Most Recent Events

    • 05 May 2014 According to Chinese Clinical Trial Register Record, status changed from recruiting to completed.
    • 19 Dec 2013 Status changed from not yet recruiting to recruiting as reported by Chinese Clinical Trial Register Record.
    • 28 Mar 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top